Whether GLP-1 drugs completely offset the increased risk of cardiovascular disease associated with COVID-19 needs to be thoroughly evaluated
To check the risks and benefits of the drugs, researchers reviewed the medical records of more than 18,000 kidney transplant recipients with diabetes between 2013 and 2020
Tirzepatide keeps showing up in weight-loss talks
It offers a fresh approach for people living with obesity and diabetes, making it one of the most advanced treatments available today
I was very satisfied and impressed with the results and the experience
Then, in 2022, a higher 2 mg dose gained approval, with clinical trials showing up to 73 percent of type 2 diabetic users achieving the recommended blood sugar levels of less than 7 percent, as recommended by the American Diabetes Association